Oocyte and embryo metabolism are closely linked with their subsequent developmental capacity. Lipids are a potent source of cellular energy, yet little is known about lipid metabolism during oocyte maturation and early embryo development. Generation of ATP from lipids occurs within mitochondria via beta-oxidation of fatty acids, with the rate-limiting step catalyzed by carnitine palmitoyl transferase I (CPT1B), a process also requiring carnitine. We sought to investigate the regulation and role of beta-oxidation during oocyte maturation and preimplantation development. Expression of Cpt1b mRNA, assessed by real-time RT-PCR in murine cumulus-oocyte complexes (COCs), increased following hormonal induction of oocyte maturation and ovulation in vivo with human chorionic gonadotropin (5 IU) and in embryos reaching the blastocyst stage. Beta-oxidation, measured by the production of 3 H 2 O from [ 3 H]palmitic acid, was significantly increased over that in immature COCs following induction of maturation in vitro with epidermal growth factor (3 ng/ml) and follicle-stimulating hormone (50 mIU/ml). The importance of lipid metabolism for oocyte developmental competence and early embryo development was demonstrated by assessing the rate of embryo development following inhibition or upregulation of betaoxidation with etomoxir (an inhibitor of CPT1B) or L-carnitine, respectively. Inhibition of beta-oxidation during oocyte maturation or zygote cleavage impaired subsequent blastocyst development. In contrast, L-carnitine supplementation during oocyte maturation significantly increased beta-oxidation, improved developmental competence, and in the absence of a carbohydrate energy supply, significantly increased 2-cell cleavage. Thus, carnitine is an important cofactor for developing oocytes, and fatty acids are an important energy source for oocyte and embryo development.
INTRODUCTION
The maturation of mammalian oocytes in vivo is induced by the luteinizing hormone surge, which initiates a cascade of events, including resumption of meiosis, expansion of the surrounding cumulus cells, and finally, ovulation. Both before and during oocyte maturation, the oocyte grows and gradually acquires developmental competence, a term defined as the ability to be fertilized and to support subsequent embryo and, eventually, fetal development. What defines developmental competence is not clear, but oocyte quality and developmental competence are closely associated with the metabolism and metabolic rate of the oocyte and its surrounding cumulus cells [1] [2] [3] [4] [5] . Similarly, the metabolism of the preimplantation embryo is critical in determining embryo health (for review, see [6] ).
The metabolism of carbohydrates, including glucose and pyruvate, by oocytes and preimplantation embryos has been studied extensively [7] [8] [9] [10] [11] ; however, less attention has been paid to oocyte lipid metabolism or the contribution of fatty acids as an energy source for oocytes and embryos, despite oocytes and embryos from many species, such as porcine sheep and cow, containing abundant levels of lipid [12, 13] . In the cow, inhibition of b-oxidation during oocyte maturation results in decreased blastocyst development [14] , whereas inhibition throughout mouse preimplantation embryo development leads to decreased proliferation rates [15] . Mouse and human oocytes and embryos, comparatively, contain minimal endogenous lipid; however, in vitro studies have shown that mouse preimplantation embryos are capable of metabolizing radiolabeled fatty acid [16] and that b-oxidation is required for meiotic resumption in the mouse [17] . In addition to intracellular lipid reserves, analysis of human and bovine follicular fluid shows abundant levels of triglycerides and free fatty acids [18, 19] . boxidation levels in cumulus-oocyte complexes (COCs) have not been investigated directly, nor have the levels in cumulus cells versus oocytes or changes during oocyte maturation.
The b-oxidation pathway metabolizes fatty acids within mitochondria to generate cellular ATP. The initial, and ratelimiting, step in b-oxidation is the entry of activated fatty acids into the mitochondrion, which is catalyzed by carnitine palmitoyl transferase I (CPT1B) (Fig. 1) . CPT1B attaches carnitine, enabling entry of the fatty acid into the mitochondrial matrix, where carnitine is removed by CPT2 and the fatty acid enters the b-oxidation spiral, producing multiple acetylcoenzyme A (CoA) molecules from which ATP is generated via the tricarboxylic acid (TCA) cycle and the electrontransport chain (Fig. 1) .
It is becoming increasingly apparent that ATP has an essential role in determining oocyte quality [20] [21] [22] and ability to support embryo development. Complete oxidation of one glucose molecule produces approximately 30 ATP molecules [23] ; however, the oocyte and precompaction embryo have little capacity to either take up or utilize glucose for energy production [9, 24, 25] . Furthermore, during maturation, expansion of the cumulus matrix places a high demand on glucose for production of hyaluronan subunits through the hexosamine biosynthesis pathway, thus diverting glucose from the glycolytic fate [26] . Alternative energy sources found in current culture media preparations, suitable for the oocyte and preimplantation embryo, primarily include the carboxylic acids, pyruvate and lactate. However, ATP production from these could be limited by their involvement in maintaining cellular redox. In contrast, fatty acids are several-fold more energy rich than glucose, with oxidation of the fatty acid palmitate capable of generating 106 ATP molecules. Because of the potency of energy-dense lipids to generate ATP and, thus, their potential ability to support and promote oocyte maturation and embryo development, further research is needed to understand how the oocyte and early embryo may utilize lipid substrates for energy production and whether this form of metabolism is developmentally beneficial.
In the present study, we analyzed the dynamics and hormonal regulation of lipid utilization in the mouse COC during maturation and early preimplantation embryo development. Additionally, through inhibition and upregulation of the b-oxidation pathway, we investigated the importance of lipid metabolism during oocyte maturation and embryo development at the early cleavage stage.
MATERIALS AND METHODS

Materials
Equine chorionic gonadotropin (eCG; Gestyl) was purchased from Professional Compounding Centre of Australia. Human chorionic gonadotropin (hCG; Pregnyl) was purchased from Organon. Culture medium was purchased from Gibco, Invitrogen Australia Pty. Ltd. Unless stated otherwise, all other reagents were purchased from Sigma-Aldrich Pty. Ltd.
Animals
All mice were obtained from Laboratory Animal Services and were maintained on a 12L:12D photoperiod with rodent chow and water provided ad libitum. All murine experiments were approved by the University of Adelaide's Animal Ethics Committee and were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Isolation of Mouse COCs
Prepubertal (Days 21-23) C57BL/6 female mice were treated with i.p. administration of eCG (5 IU), followed by hCG (5 IU i.p.) 44 h later. The COCs were collected 44 h post-eCG (immature COCs) and 4 or 10 h (preovulatory) or 14 h (postovulatory) post-hCG. Preovulatory granulosa cells (GCs) and COCs were collected by puncture of large antral follicles with a 30-gauge needle to release cells. COCs were cleaned of large adherent masses of GCs and snap-frozen for later RNA isolation. Ovulated COCs (14 h post-hCG) were isolated by puncture of the ampulla of the oviduct. Corresponding GCs were also collected at each time point for RNA isolation by puncture of the large antral follicles. Granulosa and COC cell pellets were snap-frozen and stored at À808C for later RNA extraction.
Isolation of Mouse Embryos
For all subsequent experiments, CBA 3 C57BL/6 first filial generation (F 1 ) hybrid mice were utilized in place of C57BL/6 mice, because the F 1 strain is highly successful for the generation of gametes and embryos in vitro [27] . Female CBA 3 C57BL/6 F1 hybrid mice at 21-23 days of age underwent ovarian stimulation using eCG, administered by an i.p. injection of 5 IU at 1400 h, followed 44 h later by 5 IU of hCG (administered i.p. at 1000 h). Females were then paired overnight with males (CBA 3 C57BL/6 F1), and mating was confirmed the following morning by the presence of a copulation plug. Female mice were culled by cervical dislocation at the time required for embryo collection. For collection of zygotes and of 2-and 8-cell embryos, oviducts were collected at 27, 46, and 70 h post-hCG, respectively (1300, 0800, and 0800 h, respectively), and embryos were flushed from the reproductive tract in Hepes-buffered minimum essential medium alpha media (a-MEM) supplemented with 3 mg/ml of bovine serum albumin (BSA; fatty acid free), 100 U/ml of penicillin G, and 100 mg/ml of streptomycin sulfate. For zygotes, cumulus-enclosed embryos were briefly incubated in 50 U/ml of bovine hyaluronidase, and cumulus cells were removed with the aid of gentle pipetting. For the collection of blastocysts, uterine horns were dissected 93.5 h post-hCG (0730 h), and embryos were flushed from the reproductive tract. Denuded zygotes as well as 2-and 8-cell embryos and blastocysts were washed in fresh medium before being snapfrozen for later RNA extraction.
Gene Expression Analysis
For embryos, RNA was extracted from pools of 60 embryos using the RNAqueous-Micro Scale RNA Isolation Kit (Ambion, Applied Biosystems) following the manufacturer's protocol. For COC and GC samples, total RNA was isolated using TRIzol (Invitrogen Australia Pty. Ltd.) per the manufacturer's instructions, with the inclusion of 15 lg of Blue Glycogen (Ambion) during precipitation. Total RNA was then treated with 1 U of DNase per the manufacturer's instructions (Ambion). RNA concentration and purity were quantified using a Nanodrop ND-1000 Spectrophotometer (Biolab Ltd.). First-strand cDNA was synthesized from total RNA (500 ng for COC and GC samples or from pools of 60 embryos) using random hexamer primers (Roche) and Superscript III reverse transcriptase (Invitrogen). Real time RT-PCR was performed in triplicate for each sample on a Rotor-Gene 6000 sequence detection system (Corbett Life Science). In each reaction, 2 ll of cDNA (equivalent to 10 ng of total RNA for COCs and GC or the equivalent of one embryo), 0.2 ll of forward and reverse primers, 10 ll of SYBR Green master mix, and 7.6 ll H 2 O were added to a final volume of 20 ll. PCR cycling conditions were 508C for 2 min and 958C for 10 min, followed by 40 amplification cycles of 958C for 15 sec and 608C for 1 min. Rpl19 was used as an internal control for COC and GC samples, and Rn18s was used for embryo samples. All primers were QuantiTect primer assays (Qiagen) and were shown to have comparable amplification efficiency as the internal control. Analysis of the dissociation curves confirmed that a single product was amplified in all reactions. Controls included omission of the cDNA template or RT enzyme in otherwise complete reaction mixtures; each showed no evidence of product amplification or primer dimer. Real-time RT-PCR data were analyzed using the 2 À(DDCT) method [28] for quantification relative to a reference or calibrator sample. Results for each PCR were normalized to the calibrator (GC RNA from prepubertal, unstimulated female mice), which was given the arbitrary value of one.
FIG. 1.
Schematic representation of b-oxidation pathway and its inhibition by etomoxir. The rate-limiting step in b-oxidation is the transport of activated fatty acids (fatty acyl-CoA) into mitochondria. This is catalyzed by CPT1B, which transfers carnitine for CoA, forming fatty acyl-carnitine. Once inside the mitochondrial matrix, CPT2 reforms fatty acyl-CoA, which enters the b-oxidation cycle, generating acetyl-CoA molecules from which ATP is generated through the TCA cycle and electron-transport chain. Etomoxir irreversibly binds and inhibits CPT1B activity, preventing entry of activated fatty acids into the mitochondrion and, thus, inhibiting b-oxidation.
b-Oxidation Assay
Levels of b-oxidation were measured in denuded oocytes, COCs, and early embryos using a modification of the method described by Cabrero et al. [29] . From 20 to 30 oocytes, COCs, or presumptive zygotes were added to a well of a 96-well plate containing bicarbonate-buffered a-MEM supplemented with 0.3 mM 9,10-[ 3 H]palmitate (specific activity, 50 Ci/mmol; 12.5 lCi/ well), 3 mg/ml of BSA (fatty acid free), 0.25 mM L-carnitine, and 3 mM Dglucose in a final volume of 100 ll. Oocytes, COCs, or embryos were incubated at 378C in an atmosphere of 6% CO 2 and 94% air for 20 h, after which oxidation of 9,10-[ 3 H]palmitate was measured by the production of 3 H 2 O in the medium. Excess 9,10-[ 3 H]palmitate was removed by trichloroacetic acid (TCA) precipitation, which was performed twice by the addition of an equal volume of 10% TCA, incubation on ice for 30 min, and centrifugation at 13 000 3 g for 5 min. An aliquot of the resulting supernatant (190 ll) was treated with 950 ll of methanol:chloroform (2:1) and 380 ll of 2M KCl:HCl and then centrifuged at 3000 3 g for 5 min. An aliquot of the supernatant (0.5 ml) was removed and counted following the addition of scintillation fluid. Each treatment was performed in duplicate and included duplicate blank wells containing no cells. The relative levels of b-oxidation were calculated by first subtracting the mean of the duplicate blank wells, then by the ratio of labeled product (Ci) to labeled substrate (50 Ci/mmol), corrected by product recovery, and the proportion of tritiated to unlabeled hydrogen atoms (i.e., two resultant acetyl-CoA molecules out of a total of 16). Data are presented as fmol per oocyte/COC/embryo per hour. Calculations were based on the assumptions of no loss of tritiated water through evaporation and complete oxidation of the radiolabeled substrate.
Denuded Oocyte and COC b-Oxidation Assay
For b-oxidation assays, COCs were obtained from prepubertal, 21-to 23-day-old, F 1 CBA 3 C57BL/6 mice 48 h after i.p. injection of 5 IU eCG. COCs were isolated and adherent GCs removed in Hepes-buffered a-MEM supplemented with 3 mg/ml of BSA (fatty acid free), 100 U/ml of penicillin G, and 100 mg/ml of streptomycin sulfate. For denuded oocytes and immature, unexpanded COCs (see Figs. 2C, 3A, and 5), 5 lM milrinone (a selective phosphodiesterase inhibitor) was included in the isolation medium to maintain meiotic arrest. Denuded oocytes were obtained by manual pipetting of immature COCs utilizing a finely drawn glass pipette to remove all adherent cumulus cells. To each well, 20-30 COCs or denuded oocytes were added to bicarbonate-buffered a-MEM supplemented with 5 lM milrinone, 0.3 mM 9,10-[ 3 H]palmitate (12.5 lCi/well), 3 mg/ml of BSA (fatty acid free), 0.25 mM L-carnitine, and 3 mM D-glucose in a final volume of 100 ll.
The COC in vitro maturation (see Figs. 2C, 3A, and 5) was carried out in either 3 mg/ml of BSA (fatty acid free)-or 5% fetal calf serum (FCS)-supplemented medium [30, 31] . To each well, 20-30 COCs were added to bicarbonate-buffered a-MEM supplemented with 50 mIU/ml of recombinant human follicle-stimulating hormone (FSH), 3 ng/ml of epidermal growth factor (EGF), 0.3 mM 9,10-[ 3 H]palmitate (12.5 lCi/well), 0.25 mM L-carnitine, and 3 mM D-glucose with either 5% FCS or 3 mg/ml of BSA in a final volume of 100 ll. Culture treatments involved the presence or absence of 100 lM etomoxir (see Fig. 3A ). The effect of etomoxir on b-oxidation during oocyte maturation was assessed in 5% FCS-supplemented medium (see Fig. 3A ). The dose of etomoxir (100 lM) was chosen based on dose-response data (Supplemental Figure S1 ; all Supplemental Data are available at www.biolreprod.org) and on previous reports assessing the effect of etomoxir on oocytes [17] .
In the experiment designed to measure the effect of L-carnitine on b-oxidation in unexpanded COCs and during in vitro oocyte maturation (see Figure 5 ), L-carnitine was either omitted from the assay or supplemented at a concentration of 1 mM. The dose of 1 mM L-carnitine was chosen based on previous literature [17, 32] and on initial experiments to test dose responses (Supplemental Figure S2) .
Zygote Production and Embryo b-Oxidation Assay
To measure b-oxidation following fertilization, during the zygote to 2-cell transition (see Figure 4B ), COCs were isolated from the oviduct at 13-14 h post-hCG and fertilized in vitro. Sperm were collected from a CBA 3 C57BL/6 F 1 male from the vas deferens and the caudal region of the epididymis. Sperm were capacitated in bicarbonate-buffered a-MEM supplemented with 3 mg/ml of BSA (fatty acid free) for 1 h at 378C in an atmosphere of 6% CO 2 and 94% air. Following capacitation, COCs and sperm (35 000 sperm/ml) were coincubated in bicarbonate-buffered a-MEM supplemented with 3 mg/ml of BSA for 4 h at 378C in an atmosphere of 6% CO 2 and 94% air. Presumptive zygotes were stripped of any remaining cumulus cells and sperm by manual pipetting, and 20-30 zygotes were added to a well of a 96-well plate containing bicarbonate-buffered a-MEM supplemented with 0.3 mM 9,10-[ 3 H]palmitate (12.5 lCi/well), 3 mg/ml of BSA (fatty acid free), 0.25 mM L-carnitine, and 3 mM D-glucose in a final volume of 100 ll. Treatment involved the presence or absence of 100 lM etomoxir (see Figure 4B ).
FIG. 2. b-Oxidation is significantly upregulated in COCs but not in
GCs during oocyte maturation and ovulation. Analysis of Cpt1b expression in murine COCs (A) or GCs (B) at 44 h after eCG stimulation or subsequent hCG administration at 4, 10, or 14 h is shown. Messenger RNA expression was normalized to Rpl19 and is presented as the mean 6 SEM (n ¼ 3 independent experiments). b-Oxidation was assessed as the production of
Embryo Production and Assessment of Embryo Morphology and Development
For in vitro maturation, COCs were cultured in groups of 20 in bicarbonatebuffered a-MEM supplemented with 50 mIU/ml of recombinant human FSH, 3 ng/ml of EGF, 0.25 mM L-carnitine, 3 mM D-glucose, and 5% (v/v) FCS with suitable treatments in drops of 100 ll overlaid with mineral oil and incubated at 378C in an atmosphere of 6% CO 2 and 95% air for 16 h. Culture treatments involved medium supplemented with or without 100 lM etomoxir (see Figure  3C ). In experiments assessing the effect of L-carnitine during in vitro maturation (see Figures 5B and 6 ), FCS was replaced by 1 mg/ml of fetuin in the culture medium. Following in vitro maturation, COCs were washed twice and fertilized in vitro as described above. Resulting zygotes were cultured in groups of 12-15 in 20-ll drops of bicarbonate-buffered a-MEM supplemented with 3 mg/ml of BSA (fatty acid free) overlaid with mineral oil at 378C in an atmosphere of 6% CO 2 and 94% air, with or without 100 lM etomoxir (see Figure 4C ). In experiments assessing the effects of L-carnitine during maturation (see Figures 5B and 6 ), the culture medium utilized for embryo development was Vitro Cleave (COOK Australia).
In experiments assessing the effect of L-carnitine on embryo development from the zygote to the 2-cell stage (see Figure 7) , presumptive zygotes were flushed from the reproductive tract of 6-week-old CBA 3 C57BL/6 F 1 female mice following gonadotropin treatment and mating as described above and were cultured in G1 medium [27] without glucose, pyruvate, lactate, or a protein source (human serum albumin [HSA] or BSA) but supplemented with 0.2% polyvinylpyrrolidone (PVP) in either the absence or the presence of Lcarnitine (1 or 5 mM).
Twenty-four hours following in vitro fertilization (Day 2), the fertilization rate was assessed, and 2-cell embryos (see Figures 3B, 4C, 
Differential Nuclear Staining
On Day 5 of embryo culture, blastocysts and hatching blastocysts were subjected to a differential staining protocol for identification of cells within the fetal precursor-inner cell mass (ICM) and placental precursor-trophectoderm (TE) layer [33] . The zona was dissolved by incubation in 0.5% pronase at 378C. Blastocysts were then transferred to 10 mM tri-nitrobenzenesulfonic acid for 10 min at 48C, followed by incubation in 0.1 mg/ml of anti-dinitrophenyl-BSA for 10 min at 378C, then 5 min at 378C in guinea pig serum containing 10 lg/ml of propidium iodide. Blastocysts were then stained overnight in 6 lg/ml of bisbenzimide in ethanol at 48C. The following day, blastocysts were washed in 100% ethanol and mounted on a siliconized slide in a glycerol drop. The number of pink (TE) and blue (ICM) fluorescent cells was assessed, blinded to treatment group, using a fluorescent microscope under an ultraviolet filter at 4003 magnification.
Statistical Analysis
Results are presented as the mean 6 SEM. Real-time RT-PCR expression analysis experiments were performed in triplicate and analyzed by performing a one-way ANOVA and a Tukey post hoc test. One-way ANOVA and Tukey post hoc test were used to compare rates of b-oxidation between unexpanded COCs and during oocyte maturation in vitro. An unpaired t-test was used in the case of comparison of rates of b-oxidation between two cell types or within developmental stages for etomoxir and L-carnitine treatments. For embryo development data, an unpaired t-test was used to compare differences between treatments, either etomoxir or L-carnitine, on each day of development. A oneway ANOVA was used to analyze the effect of L-carnitine on ATP accumulation in the COC and on development from zygote to 2-cell embryo (see Figure 7) . For all statistical analyses, GraphPad Prism version 5.01 for Windows (GraphPad Software, Inc.) was used. Differences were considered to be significant at P , 0.05.
RESULTS
Hormonal Regulation of Cpt1b in COCs and Increased b-Oxidation During Oocyte Maturation
Carnitine palmitoyl transferase I is the rate-limiting step in the oxidation of fatty acids, and its activity is regulated both at the level of mRNA expression [34] and by allosteric inhibition [35] . We determined whether Cpt1b expression is hormonally regulated in COCs and GCs in response to ovulatory gonadotropins. Compared to immature COCs, expression of Cpt1b was not significantly different 4 h after the administration of hCG in mature COCs (Fig. 2A) . A significant 2.1-fold increase in Cpt1b expression, however, was observed 10 h post-hCG in COCs compared to 44 h post-eCG ( Fig. 2A) . This ]palmitic acid is shown (A; n ! 5 experimental replicates, representative of 58-110 denuded oocytes or COCs per group, presented as the mean 6 SEM, with unpaired t-test performed on the effect of etomoxir at each developmental stage; *P , 0.05, **P , 0.01, ***P , 0.0001). The importance of b-oxidation during oocyte maturation for subsequent oocyte developmental competence was assessed by the rate of embryo development following in vitro fertilization of COCs matured in vitro in the presence or absence of 100 lM etomoxir (B), but fertilization and embryo development were assessed in the absence of etomoxir (data presented as mean % embryo development 6 SEM, n ! 3 experimental replicates, representative of 89-91 oocytes per treatment, with unpaired t-test performed within developmental stage; *P , 0.05).
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level of expression was maintained and was not significantly different in COCs following ovulation at 14 h post-hCG. In contrast, no significant induction of Cpt1b expression in GCs was found at any of the time points sampled (Fig. 2B) .
Because CPT1B is the rate-limiting step in b-oxidation, our observations of Cpt1b mRNA expression suggest that fatty acid/b-oxidation, which requires CPT1B activity, increases as the COC undergoes oocyte maturation in vivo. To test this, we measured b-oxidation in vitro in unexpanded, immature COCs (44 h post-eCG) and compared those results to data for in vitromatured COCs, which are the phenotypic equivalent of COCs at 14 h post-hCG [36] [37] [38] .
b-Oxidation was detected in unexpanded COCs containing immature oocytes. The level of b-oxidation was 8.2-fold higher in these COCs than in their denuded oocyte counterparts (compare denuded oocyte vs. immature COC data in Fig. 2C ), indicating that the majority of b-oxidation occurs in the cumulus cells of the COC. Following in vitro maturation, b-oxidation was not significantly different from that in unexpanded, immature COCs (compare immature COC vs. BSA in vitro-matured COC data in Fig. 2C ). The inclusion of 5% FCS during in vitro maturation, to permit cumulus-oocyte expansion, did result in a significant 2.1-fold increase in b-oxidation when compared to immature, unexpanded control COCs (Fig. 2C) , consistent with the level of increase in Cpt1b expression seen after maturation in vivo ( Fig. 2A) .
These results show that the expression of Cpt1b, the gene responsible for the rate-limiting step in b-oxidation, is significantly upregulated following the luteinizing hormone (hCG) surge, which induces oocyte maturation and ovulation. This was supported by functional analysis whereby b-oxidation, as measured by the production of 3 H 2 O in the medium, was significantly increased during in vitro maturation of COCs (in FCS-supplemented medium) when compared to immature control COCs.
b-Oxidation Is Essential for Oocyte Developmental Competence
Etomoxir is a well-characterized, nonreversible inhibitor of the rate-limiting step of b-oxidation [39] (Fig. 1) . To determine the effect of inhibiting b-oxidation on oocyte developmental competence, oocytes and COCs were treated with 100 lM etomoxir. As shown in Figure 3A , etomoxir was effective at inhibiting b-oxidation under all conditions tested. A significant 8.1-and 4.4-fold decrease was found in b-oxidation in denuded oocytes and immature COCs, respectively (Fig. 3A) . Similarly, for COCs matured in vitro in the presence of etomoxir, a significant 6.5-fold reduction in b-oxidation was observed when compared to untreated controls (see in vitro-matured COC data in Fig. 3A) . 
BETA-OXIDATION IN OOCYTE AND EMBRYO DEVELOPMENT
Etomoxir was used to inhibit b-oxidation during oocyte maturation only (i.e., the first 16 h of COC culture in the presence of FSH, EGF, and 5% FCS), and the rate of embryo development following in vitro fertilization was assessed. Cumulus expansion was not affected by etomoxir treatment (data not shown), as previously described [17] , and COCs were similarly free of adherent cumulus cells following fertilization when compared to untreated controls (data not shown). Under the maturation conditions used here, no effect of etomoxir treatment on development to metaphase II formation was found, as assessed by the presence of a polar body (data not shown). Treatment of COCs with etomoxir during oocyte maturation only significantly decreased the rate of embryo development on Days 3 and 5 (Fig. 3B) .
These experiments show that inhibition of b-oxidation during oocyte maturation results in decreased oocyte developmental competence, as assessed by a significantly decreased rate of embryo development with significantly fewer blastocysts at the end of the culture period, thereby demonstrating an important role for b-oxidation during oocyte maturation.
Induction of Cpt1b During Preimplantation Embryo Development and the Essential Requirement of b-Oxidation by the Early Embryo
Expression of Cpt1b was measured following fertilization and throughout preimplantation embryo development in the mouse at the zygote, 2-cell, 8-cell, and blastocyst stages. We were unable to detect Cpt1b transcripts at the zygote, 2-cell, and 8-cell stages. Cpt1b, however, was induced and detectable at the blastocyst stage (Fig. 4A) .
Although expression of Cpt1b was not detectable at the zygote or 2-cell stage, these embryos were capable of b-oxidation that was significantly inhibited by the presence of etomoxir (Fig. 4B) . At the least, this finding indicates that this enzyme is maternally inherited and active in the 2-cell embryo until induction of its own transcripts at the blastocyst stage.
To assess the importance of b-oxidation during the zygote to 2-cell transition following in vitro fertilization, presumptive zygotes were cultured under control conditions or in medium supplemented with etomoxir. Two-cell embryos were washed and then cultured to the blastocyst stage in the absence of etomoxir, and the rate of embryo development was assessed at the 2-cell, 4-to 8-cell, and blastocyst stages. Culture of presumptive zygotes in etomoxir led to significant decreases in the rate of embryo development on Days 3 and 5 (Fig. 4C) .
These results show that although the zygote does not have detectable Cpt1b mRNA, b-oxidation is occurring and is essential for normal embryo development.
L-Carnitine Supplementation Significantly Increases b-Oxidation in the COC and Improves Oocyte Developmental Competence
After we had determined that inhibition of b-oxidation during oocyte maturation in vitro had detrimental effects on the developmental capacity of the oocyte (Fig. 3) , we next sought to investigate whether upregulation of this metabolic pathway could improve oocyte developmental potential. b-Oxidation was shown to occur basally in the absence of exogenous L-carnitine in vitro (Fig. 5A) . Supplementation of the culture medium with 1 mM L-carnitine caused a significant 2-fold increase in b-oxidation in immature COCs (see immature COC data in Fig. 5A ). Similarly, during in vitro maturation, L-carnitine supplementation (1 mM) led to a significant 3.7-and 1.4-fold increase in b-oxidation during in vitro maturation in BSA-supplemented and FCS-supplemented medium, respectively (compare BSA vs. FCS data in Fig. 5A ).
After we had established that L-carnitine was able to significantly increase b-oxidation during in vitro maturation of the COC, we next assessed whether L-carnitine supplementation during oocyte maturation had an effect on subsequent embryo development. Following in vitro maturation with or without L-carnitine supplementation (1 mM), COCs were washed and fertilized in vitro, and the rate of embryo development was assessed. Supplementation of the culture medium with L-carnitine during in vitro maturation alone significantly increased the rate of embryo development to the blastocyst stage (Fig. 5B ).
These results demonstrate that supplementation of culture medium during in vitro maturation of oocytes significantly upregulates b-oxidation in the COC and results in a significant improvement in oocyte developmental competence, as assessed by increased blastocyst development following fertilization.
L-Carnitine Supplementation During In Vitro Maturation Significantly Increases the Number of Hatching Blastocysts and ICM Cell Allocation
Because L-carnitine supplementation during in vitro maturation alone significantly increased the number of embryos developing to blastocyst (Fig. 5B) , we further assessed the quality of these embryos by the ratio of hatching to nonhatching blastocysts and by quantitative analysis of blastocyst cell number and allocation to the ICM. On Day 5 of embryo development, a significant increase in the proportion of hatching blastocysts was observed (Fig. 6A) .
The number of ICM cells was significantly increased in blastocysts derived from oocytes matured in the presence of L-carnitine (Fig. 6E) . No difference was found in the total or TE cell numbers (Fig. 6, D and F, respectively) . However, the ratio of ICM to total cell number was significantly increased in response to L-carnitine (Fig. 6G) . 
BETA-OXIDATION IN OOCYTE AND EMBRYO DEVELOPMENT
and because inhibition of this pathway inhibited embryo development (Fig. 4) , we sought to determine whether L-carnitine, in the absence of glucose, lactate, pyruvate, and an extracellular protein source (i.e., no HSA or BSA), could increase utilization of internal lipid stores in the zygote and promote cleavage to the 2-cell stage. L-Carnitine supplementation, in a dose-dependant manner, led to increased numbers of 2-cell embryos, with significantly higher cleavage rates occurring in 5 mM L-carnitine compared to 0 mM (Fig. 7) . Presumptive zygotes cultured under control conditions (i.e., in the presence of glucose, lactate, and pyruvate) resulted in a mean 2-cell cleavage rate of 80% 6 12.6% in these same experiments (n ¼ 3).
These data show that in the absence of an extracellular energy supply, the inclusion of L-carnitine in the culture medium significantly increases the number of murine zygotes cleaving to 2-cell embryos, indicating that L-carnitine promotes the use of internal lipid stores for energy production.
DISCUSSION
Little is known about the metabolism of exogenous or endogenous stores of lipids by the COC. In the current study, we have shown that b-oxidation, the metabolic pathway responsible for the generation of cellular energy from lipids, is significantly upregulated both in vivo and in vitro during oocyte maturation. Furthermore, expression of the initial and rate-limiting enzyme of b-oxidation, Cpt1b, was significantly upregulated in the COC in response to ovulatory hCG. Although CPT1B activity was not directly measured, this is one possible mechanism that could be responsible for the increase in b-oxidation. In contrast, no hormonal regulation was observed in GCs, suggesting that cumulus cell lipid metabolism is under coregulation by oocyte-secreted factors, paracrine peptides already being known to regulate cumulus cell hexose metabolism, cholesterol synthesis, and amino acid transport [40] .
Although it is difficult to determine total b-oxidation rates or to make definitive comparisons with glycolytic activity [41] because of the numerous substrates available for b-oxidation in addition to endogenous stores within the COC, the levels of b-oxidation measured here provide us with an understanding of the relative levels of b-oxidation within the oocyte and cumulus cells and of how this changes throughout maturation and early embryo development. Interestingly, the increase in b-oxidation during oocyte maturation in vitro was only observed when 5% FCS was present (Fig. 2C ), indicating that one or more constituents of FCS are capable of promoting b-oxidation. L-Carnitine is likely to be present in FCS and contributes, at least in part, to the increased levels of b-oxidation during maturation, because L-carnitine supplementation of BSA-containing medium results in b-oxidation levels similar to that achieved with FCS-supplemented medium alone (Fig. 5A) .
We have also shown, by modulating the b-oxidation pathway, that this pathway has an important role in establishing oocyte developmental competence. First, inhibiting b-oxidation with etomoxir during oocyte maturation in vitro resulted in decreased subsequent embryo development. This builds on previous work by Downs [17] , which has shown the involvement of b-oxidation in oocyte meiotic resumption, with etomoxir treatment associated with significant impairment in germinal vesicle breakdown. Thus, b-oxidation plays essential roles in both the nuclear and cytoplasmic processes that are required for resumption of meiosis and acquisition of oocyte developmental competence.
Second, we show that upregulation of b-oxidation during oocyte maturation in vitro by L-carnitine increases oocyte developmental competence, as manifested by significant improvements in embryo development. L-Carnitine supplementation has also been shown to decrease oocyte cytoskeletal damage and to have beneficial effects on murine embryo development in vitro [42, 43] . This was mostly attributed to the antioxidant effect of L-carnitine, and no doubt exists that oxidative stress influences oocyte developmental competence during in vitro maturation (for review, see [44] ). However, L-carnitine (and etomoxir) have been shown in other systems to affect mitochondrial membrane potential [32, 45, 46] , and oocyte mitochondrial parameters such as these are associated with altered embryo developmental potential [47, 48] . Thus, it will be of interest to determine whether L-carnitine, in COCs, affects mitochondrial membrane potential, mitochondrial distribution, and/or levels of ATP and ADP. Our demonstration that L-carnitine supplementation results in significant upregulation of the b-oxidation pathway suggests that the increase in developmental potential as a result of L-carnitine inclusion in culture medium may be the result primarily of increased generation of ATP, which is closely associated with oocyte quality [20] [21] [22] .
In the cow, oocytes and embryos are capable of completing maturation and cellular divisions without provision of an exogenous energy supply, implying a reliance on endogenous lipid energy stores (for review, see [49] ). In contrast, mouse and human oocytes contain minimal lipid stores [50] , and previous work has demonstrated that mouse oocytes are unable to complete maturation in the absence of an exogenous energy supply [51] and require pyruvate and lactate for cleavage to occur [1] . We show here, however, that under similarly depleted circumstances (i.e., in the absence of glucose, pyruvate, lactate, and an extracellular protein source), the presence of L-carnitine increases the rate of cleavage to the 2-cell stage. This result indicates that the early mouse embryo is capable of utilizing intracellular lipid stores in response to L-carnitine and provides further evidence that L-carnitine, rather than acting as an antioxidant, promotes embryo development by increasing energy production. Physiologically, carnitine, an 916 essential metabolite, is derived both from dietary sources and from endogenous biosynthesis. Carnitine levels in circulation are variable, and interestingly, lower serum levels of L-carnitine have been reported in women with polycystic ovarian syndrome [52] . The ability of L-carnitine to promote b-oxidation of lipids in the COC and zygote indicates that even small differences in circulating carnitine may influence oocyte developmental competence. Likewise, because a relatively small amount of fatty acid generates abundant energy, even minor differences in the lipid content of oocytes may have significant impact on oocyte ATP levels.
The metabolism of substrates, such as glucose, lactate, and pyruvate, by the mammalian oocyte and preimplantation embryo have been studied extensively, and considerable effort has been made, particularly in embryo culture media, to formulate media that meet the metabolic requirements of oocytes and embryos for these substrates. In contrast, current commercial defined media formulations used for oocyte and embryo culture do not include a fatty acid substrate [10, 11] , despite follicular fluid, the physiological environment in which the oocyte matures in vivo, containing both lipoproteins and free fatty acids [18, 53] . It is also unlikely that current commercial media preparations provide sufficient levels of L-carnitine for b-oxidation. Because of the poorer developmental potential of oocytes matured in vitro compared to their counterparts matured in vivo [54] , further optimization of culture medium should take fatty acid metabolic activity into consideration. We have now shown that lipid metabolism is hormonally regulated and increases in the COC during oocyte maturation in vivo. Furthermore, we have shown that inclusion of a physiological metabolite, L-carnitine, during oocyte maturation in vitro is able to increase lipid metabolism and improve embryo development. Its inclusion in culture media formulations is thus expected to better mimic the normal in vivo environment and lead to improvements in oocyte and embryo quality in human clinics and in agriculturally important species.
